Premier Path Wealth Partners LLC raised its holdings in Corteva, Inc. (NYSE:CTVA – Free Report) by 54.0% in the first quarter, Holdings Channel.com reports. The fund owned 18,487 shares of the company’s stock after buying an additional 6,482 shares during the quarter. Premier Path Wealth Partners LLC’s holdings in Corteva were worth $1,548,000 at the end of the most recent reporting period.
Several other institutional investors also recently made changes to their positions in CTVA. JPL Wealth Management LLC purchased a new position in shares of Corteva in the 3rd quarter valued at about $25,000. Garton & Associates Financial Advisors LLC purchased a new stake in Corteva during the fourth quarter worth about $27,000. Bank of Jackson Hole Trust purchased a new stake in Corteva during the fourth quarter worth about $28,000. Cornerstone Financial Management LLC acquired a new position in Corteva during the fourth quarter worth about $29,000. Finally, Basepoint Wealth LLC purchased a new position in Corteva in the fourth quarter valued at about $30,000. 81.54% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of equities research analysts have recently issued reports on the stock. CICC Research lifted their price target on shares of Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a research report on Wednesday, May 13th. The Goldman Sachs Group upped their price target on Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a report on Tuesday, April 14th. Jefferies Financial Group raised their price objective on Corteva from $95.00 to $97.00 in a research note on Thursday, May 7th. Mizuho lifted their price objective on Corteva from $82.00 to $94.00 and gave the stock an “outperform” rating in a report on Wednesday, April 15th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on Corteva from $90.00 to $100.00 in a research report on Monday, May 11th. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $88.81.
Corteva Stock Up 1.5%
Shares of NYSE CTVA opened at $84.66 on Wednesday. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $85.63. The firm’s 50 day moving average price is $79.51 and its 200 day moving average price is $76.54. The firm has a market cap of $56.62 billion, a P/E ratio of 49.80, a price-to-earnings-growth ratio of 2.55 and a beta of 0.57. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47.
Corteva (NYSE:CTVA – Get Free Report) last released its earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping the consensus estimate of $1.18 by $0.32. The firm had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. Corteva’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period in the previous year, the company earned $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, sell-side analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current year.
Corteva Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were given a $0.18 dividend. The ex-dividend date of this dividend was Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s payout ratio is currently 42.35%.
Corteva Profile
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
See Also
- Five stocks we like better than Corteva
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
